Background: A serum antibody directed against astrocytes is present in a high proportion of patients with neuromyelitis optica (NMO). The pathogenicity of the antibody is uncertain because no consistent astrocyte lesion is known to occur in NMO.
Objective: To determine whether there is an astrocyte lesion in NMO and if this differs from astrocyte changes in multiple sclerosis (MS).
Methods: Astrocyte pathology in early (still-myelinated) lesions and subacute NMO and MS lesions was examined immunohistochemically and in sections stained for astrocytes using routine histological techniques.
Results: Demyelination in early NMO lesions is accompanied by oligodendrocyte apoptosis in a pattern identical to that seen in MS and this is preceded by an abrupt destruction of perivascular astrocytes. Reparative astrogliosis is effected by a population of unipolar, new astrocytes. Evidence of a different type of astrocyte lesion was found in MS.
Discussion: The findings add to experimental evidence that the antibody is pathogenic. They also raise the possibility that demyelination in MS may be a bystander effect of an astrocyte lesion, i.e. that MS is not a disease primarily of myelin and oligodendrocytes.
McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121-127.
2.
Sobel RA and Moore GRW.Demyelinating diseases. In: Love S, Louis DN, Ellison DW (eds) Greenfield’s Neuropathology. Vol. 2, 8th edn. Oxford: Oxford University Press, 2008.
3.
Baker HW, Balla JI, Burger HG, Ebeling P. and Mackay IRMultiple sclerosis and autoimmune diseases. Aust N Z J Med1972; 2: 256-260.
4.
Wingerchuk DM , Lennon VA, Lucchinetti CF, Pittock SJ and Weinshenker BGThe spectrum of neuromyelitis optica. Lancet Neurol2007 ; 6: 805-815.
5.
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106-2112.
6.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS and Hinson SRIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med2005; 202: 473-477.
7.
Takahashi T. , Fujihara K., Nakashima I., et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med2006; 210: 307-313.
8.
Fazio R., Malosio ML, Lampasona V., et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler2009; 15: 1153-1163.
9.
Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology2007; 69: 2221-2231.
10.
Kinoshita M. , Nakatsuji Y., Moriya M., et al. Astrocytic necrosis is induced by anti aquaporin-4 antibody-positive serum. Neuroreport2009; 20: 508-512.
11.
Bradl M., Misu T., Takahashi T., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol2009; 66: 630-643.
12.
Bennett JL, Lam C., Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol2009; 66: 617-629.
13.
Lucchinetti CF, Mandler RN, McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica . Brain2002; 125: 1450-1461.
14.
Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain2007; 130: 1194-1205.
15.
Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain2007; 130: 1224-1234.
16.
Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med2006 ; 209: 269-275.
17.
Prineas JW, Barnard RO, Kwon EE, Sharer LR and Cho ESMultiple sclerosis: remyelination of nascent lesions. Ann Neurol1993; 33: 137-151.
18.
Prineas JW, Kwon EE, Cho ES and Sharer LRContinual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann N Y Acad Sci1984; 436: 11-32.
19.
Johnson MD, Lavin P. and Whetsell Jr WOFulminant monophasic multiple sclerosis, Marburg’s type. J Neurol Neurosurg Psychiatry1990; 53: 918-921.
20.
Henderson AP , Barnett MH, Parratt JD and Prineas JWMultiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol2009; 66: 739-753.
21.
Prineas JW, Kwon EE, Goldenberg PZ, Cho ES and Sharer LRInteraction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest1990 ; 63: 624-636.
de Vries HEPostvaccinial Perivenous Encephalitis. Amsterdam : Elselvier, 1960, pp.57-58.
24.
Bignami A. and Dahl D.Gliosis. In: Kettenmann H, Ransom BR (eds) Neuroglia. Vol 1, Oxford: Oxford University Press, 1995, pp.843-858.
25.
Barres BA, Schmid R., Sendnter M. and Raff MCMultiple extracellular signals are required for long-term oligodendrocyte survival. Development1993; 118: 283-295.
26.
Rothenberg MEEosinophilia. N Engl J Med1998; 338: 1592-1600.
27.
Colodner KJ , Montana RA, Anthony DC, Folkerth RD, De Girolami U. and Feany MBProliferative potential of human astrocytes . J Neuropathol Exp Neurol2005; 64: 163-169.
28.
Scolding N. , Franklin R., Stevens S., Heldin CH, Compston A. and Newcombe J.Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain1998; 121: 2221-2228.
29.
Chang A., Nishiyama A., Peterson J., Prineas J. and Trapp BDNG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci2000; 20: 6404-6412.
30.
Reynolds BA and Weiss S.Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science1992; 255: 1707-1710.
31.
Laywell ED, Rakic P., Kukekov VG, Holland EC and Steindler DAIdentification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A2000 ; 97: 13883-13888.
32.
Gensert JM and Goldman JEHeterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol2001; 48: 75-86.
33.
Goldman JEAstrocyte lineage. In: Gazzarini RA (ed.) Myelin Biology and Disorders. Vol. 1, Amsterdam: Elselvier Academic Press, 2004, pp.311-328.
Blakemore WF and Franklin RJTransplantation of glial cells into the CNS . Trends Neurosci1991; 14: 323-327.
36.
Blakemore WF and Keirstead HSThe origin of remyelinating cells in the central nervous system. J Neuroimmunol1999; 98: 69-76.
37.
Noble M., Murray K., Stroobant P., Waterfield MD and Riddle P.Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature1988; 333: 560-562.
38.
Barnett SC, Franklin RJ and Blakemore WFIn vitro and in vivo analysis of a rat bipotential O-2A progenitor cell line containing the temperature-sensitive mutant gene of the SV40 large T antigen . Eur J Neurosci1993; 5: 1247-1260.
39.
Franklin RJWhy does remyelination fail in multiple sclerosis?Nat Rev Neurosci2002; 3: 705-714.
40.
Raine CS and Bornstein MBExperimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. J Neuropathol Exp Neurol1970; 29: 177-191.
41.
Raine CS, Hummelgard A., Swanson E. and Bornstein MBMultiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. J Neurol Sci1973; 20: 127-148.
42.
Nair A., Frederick TJ and Miller SDAstrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci2008; 65: 2702-2720.
43.
Kreutzberg GW , Blakemore WF and Graeber MBCellular pathology of the central nervous system. In: Graham DI, Lantos PL (eds) Greenfield’s Neuropathology. Vol. 1, London: Arnold, 1997, pp.85-156.
44.
Messing A. and Goldman JEAlexander Disease. In: Lazzarini RA (ed.) Myelin biology and disorders. Vol. 2, Amsterdam: Elselvier, 2004, pp.851-866.
45.
Wilke S., Thomas R., Allcock N. and Fern R.Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release. J Neuropathol Exp Neurol2004; 63: 872-881.
46.
Powers JM and McKeever PECentral pontine myelinolysis. An ultrastructural and elemental study . J Neurol Sci1976; 29: 65-81.
47.
Seehusen F. , Orlando EA, Wewetzer K. and Baumgartner W.Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions?Acta Neuropathol2007 ; 114: 597-608.
48.
Faulkner JR , Herrmann JE, Woo MJ, Tansey KE, Doan NB and Sofroniew MVReactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci2004; 24: 2143-2155.
49.
Sofroniew MVReactive astrocytes in neural repair and protection . Neuroscientist2005; 11: 400-407.
50.
Voskuhl RR, Peterson RS, Song B., et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci2009; 29: 11511-11522.
51.
Gilson J. and Blakemore WFFailure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol1993; 19: 173-181.
52.
Blakemore WFEthidium bromide induced demyelination in the spinal cord of the cat. Neuropathol Appl Neurobiol1982; 8: 365-375.
53.
Blakemore WF, Crang AJ and Evans RJThe effect of chemical injury on oligodendrocytes. In: Mimms CC, Cuzner ML, Kelly RW (eds) Viruses and Demyelinating Diseases. Vol. 1, London: Academic Press, 1983, pp.167-190.
54.
Blakemore WF and Patterson RCSuppression of remyelination in the CNS by X-irradiation. Acta Neuropathol1978; 42: 105-113.
55.
Blakemore WF , Welsh CJ, Tonks P. and Nash AAObservations on demyelinating lesions induced by Theiler’s virus in CBA mice. Acta Neuropathol1988; 76: 581-589.
56.
Franklin RJM and Goldman JERemyelination by endogenous cells. In: Lazzarini RA (ed.) Myelin Biology and Disorders 1. Vol 1, Amsterdam: Elsevier, 2004, pp.173-196.
57.
Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D. and Rodriguez D.Alexander disease: putative mechanisms of an astrocytic encephalopathy . Cell Mol Life Sci2004; 61: 369-385.
58.
Buttery PC and ffrench-Constant C.Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes . Mol Cell Neurosci1999 ; 14: 199-212.
59.
Zhang SC, Ge B. and Duncan IDTracing human oligodendroglial development in vitro. J Neurosci Res2000; 59: 421-429.
60.
Parratt JDE and Prineas JWThe astrocyte lesion in neuromyelitis optica and multiple sclerosis. Mult Scler2009; 15(Suppl. 2): S174.
61.
Sharma R., Fischer MT, Bauer J., et al. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol120: 223-236.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
